The Global Venous Thromboembolism Treatment Industry is on the brink of a transformative period, poised to witness substantial growth from US$ 1,760.42 million in 2024 to an estimated US$ 2,580.90 million by 2034. This promising surge is fueled by a robust Compound Annual Growth Rate (CAGR) of 3.9%, as revealed by the latest insights from …